Malignant catatonia and neuroleptic malignant syndrome: Revisited

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 30, Issue 6, 2006, Pages 1184-1185

  Otani, Koichi ^a   Hayashi, Hiroshi ^a   Suzuki, Akihito ^a   Aoshima, Toshiaki ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BROMOCRIPTINE; DANTROLENE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; IRON; NEUROLEPTIC AGENT; RISPERIDONE;

BIPOLAR DISORDER; BRONCHORRHEA; CATATONIA; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; ELECTROCONVULSIVE THERAPY; HUMAN; HYPERGLYCEMIA; HYPERTHERMIA; IRON BLOOD LEVEL; LETTER; LUNG DISEASE; MALIGNANT CATATONIA; MUSCLE RIGIDITY; NEUROLEPTIC MALIGNANT SYNDROME; PATHOPHYSIOLOGY; SCHIZOPHRENIA; TREATMENT FAILURE;

EID: 33745233085     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2006.03.039     Document Type: Letter

References (10)

1. Hayashi H., Aoshima T., and Otani K. Malignant catatonia with severe bronchorrhea and its response to electroconvulsive therapy. Prog Neuropsychopharmacol Biol Psychiatry 30 (2006) 310-311
2. Ishida M., Otani K., Kaneko S., Ishida H., and Kawashima S. Hyperglycemia as a symptom of neuroleptic malignant syndrome. Hum Psychopharmacol 11 (1996) 137-138
3. Mann S.C., Caroff S.N., Keck P.E., and Lazarus A. Neuroleptic malignant syndrome. Neuroleptic malignant syndrome and related conditions (2003), American Psychiatric Publishing, Inc., Washington (DC) 1-44
4. Mann S.C., Caroff S.N., Fricchione G.L., Campbell E.C., and Greenstein R.A. Malignant catatonia. In: Caroff S.N., Mann S.C., Francis A., and Fricchione G.L. (Eds). Catatonia: from psychopathology to neurobiology (2004), American Psychiatric Publishing, Inc., Washington (DC) 105-119
5. Otani K., Horiuchi M., Kondo T., Kaneko S., and Fukushima Y. Is the predisposition to neuroleptic malignant syndrome genetically transmitted?. Br J Psychiatry 158 (1991) 850-853
6. Otani K., Mihara K., Okada M., Kaneko S., and Fukushima Y. Crossover reaction between haloperidol and amoxapine for NMS. Br J Psychiatry 159 (1991) 889
7. Otani K., Kaneko S., and Fukushima Y. Lethal catatonia and NMS. Br J Psychiatry 160 (1992) 424
8. Otani K., Mihara K., Kondo T., Okada M., Kaneko S., and Fukushima Y. Treatment of neuroleptic malignant syndrome with levodopa. Hum Psychopharmacol 7 (1992) 217-221
9. Suzuki A., Kondo T., Otani K., Mihara K., Yasui-Furukori N., Sano A., et al. Association of the TaqI A polymorphism of the dopamine D2 receptor gene with predisposition to neuroleptic malignant syndrome. Am J Psychiatry 158 (2001) 1714-1716
10. Taylor M.A., and Fink M. Catatonia in psychiatric classification: a home of its own. Am J Psychiatry 160 (2003) 1233-1241